Clinical Trial Update: The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial update describes a completed study evaluating long-term activation of GIP and GLP-1 receptors, alone and in combination, in adults with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Asger Lund, MD | Conditions: Type 2 Diabetes, Obesity | NA | Status: COMPLETED